{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:43:04Z","timestamp":1792600984221,"version":"4.5.0"},"reference-count":21,"publisher":"MyJove Corporation","issue":"210","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/65647","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T20:03:17Z","timestamp":1724443397000},"source":"Crossref","is-referenced-by-count":3,"title":["Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation"],"prefix":"10.3791","author":[{"given":"Haixia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"ref1","article-title":"Penn Medicine","volume-title":"Testing for measurable\/minimal residual disease (MRD)","year":"2019","unstructured":"OncoLink Team. Penn Medicine. Testing for measurable\/minimal residual disease (MRD). https:\/\/www.oncolink.org\/cancer-treatment\/procedures-diagnostic-tests\/blood-tests-tumordiagnostic-tests\/testing-for-measurable-minimal-residualdisease-mrd. Accessed February 25, (2019)."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","type":"journal-article","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma","volume":"156","author":"Xie","year":"2021","unstructured":"Xie, Y., Elaine, S. J. How I diagnose angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 156, 1-14 (2021).","journal-title":"Am J Clin Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-99716-2_5","type":"journal-article","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"176","author":"Mariko","year":"2019","unstructured":"Mariko, Y. et al. Angioimmunoblastic T-cell lymphoma. Cancer Treat Res. 176, 99-126 (2019).","journal-title":"Cancer Treat Res"},{"issue":"20","key":"ref4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","type":"journal-article","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute lukemia","volume":"127","author":"Daniel","year":"2016","unstructured":"Daniel, A. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127 (20), 2391-2405 (2016).","journal-title":"Blood"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","type":"journal-article","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Lymphoid Neoplasms","volume":"36","author":"Rita","year":"2022","unstructured":"Rita, A. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours : Lymphoid Neoplasms. Leukemia. 36 (7), 1720-1748 (2022).","journal-title":"Leukemia"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","type":"journal-article","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Hae","year":"2014","unstructured":"Hae, Y. Y. et al. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Nat Genet. 46 (4), 371-375 (2014).","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"104294","DOI":"10.1016\/j.yexmp.2019.104294","type":"journal-article","article-title":"RHOA G17V mutation in angioimmunoblastic T-cell lymphoma:A potential biomarker for cytological assessment","volume":"110","author":"Lee","year":"2019","unstructured":"Lee, P. H. et al. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma:A potential biomarker for cytological assessment. Exp Mol Pathol. 110, 104294 (2019).","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","type":"journal-article","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Mamiko","year":"2014","unstructured":"Mamiko, S. Y. et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet. 46 (2), 171-175 (2014).","journal-title":"Nat Genet"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","type":"journal-article","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","unstructured":"Palomero, T. et al. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet. 46 (2), 166-170 (2014).","journal-title":"Nat Genet"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/leu.2017.273","type":"journal-article","article-title":"Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma","volume":"32","author":"Fujisawa","year":"2018","unstructured":"Fujisawa, M. et al. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma. Leukemia. 32 (3), 694-702 (2018).","journal-title":"Leukemia"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/cells8070646","type":"journal-article","article-title":"RHO family GTPases in the biology of lymphoma","volume":"8","author":"Voena","year":"2019","unstructured":"Voena, C. et al. RHO family GTPases in the biology of lymphoma. Cells. 8 (7), 646 (2019).","journal-title":"Cells"},{"issue":"7676","key":"ref12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature24286","type":"journal-article","article-title":"DNA sequencing an 40: past, present and future","volume":"550","author":"Shendure","year":"2017","unstructured":"Shendure, J. et al. DNA sequencing an 40: past, present and future. Nature. 550 (7676), 345-353 (2017).","journal-title":"Nature"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","type":"journal-article","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Athanasios","year":"2010","unstructured":"Athanasios, C. T. et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn. 12 (4), 425-432 (2010).","journal-title":"J Mol Diagn"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41551-017-0126-5","type":"journal-article","article-title":"Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification","volume":"1","author":"Wu","year":"2017","unstructured":"Wu, L. R. et al. Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification. Nat Biomed Eng. 1, 714-723 (2017).","journal-title":"Nat Biomed Eng"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.biophys.32.110601.141800","type":"journal-article","article-title":"The thermodynamics of DNA structural motifs","volume":"33","author":"John","year":"2004","unstructured":"John, S. J. et al. The thermodynamics of DNA structural motifs. Annu Rev Biophys Biomol Struct. 33, 415-440 (2004).","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1373\/clinchem.2008.113035","type":"journal-article","article-title":"PCR-based methods for the enrichment of minority alleles and mutations","volume":"55","author":"Coren","year":"2009","unstructured":"Coren, A. M. et al. PCR-based methods for the enrichment of minority alleles and mutations. Clin Chem. 55 (4), 632-640 (2009).","journal-title":"Clin Chem"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-022-01618-w","type":"journal-article","article-title":"Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research","volume":"36","author":"Eliza","year":"2022","unstructured":"Eliza, M. L. et al. Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research. Leukemia. 36 (9), 2151-2164 (2022).","journal-title":"Leukemia"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/bios12080597","type":"journal-article","article-title":"Hot-spot-specific probe (HSSP) for rapid and accurate detection of KRAS mutations in colorectal cancer","volume":"12","author":"Lee","year":"2022","unstructured":"Lee, H. J. et al. Hot-spot-specific probe (HSSP) for rapid and accurate detection of KRAS mutations in colorectal cancer. Biosensors. 12 (8), 597 (2022).","journal-title":"Biosensors"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"e109714","DOI":"10.1371\/journal.pone.0109714","type":"journal-article","article-title":"Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR","volume":"9","author":"Matsubara","year":"2014","unstructured":"Matsubara, R. N. et al. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR. PLoS One. 9 (10), e109714 (2014).","journal-title":"PLoS One"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1101\/gr.3.3.S30","type":"journal-article","article-title":"General concepts for PCR primer design","volume":"3","author":"Dieffenbach","year":"1993","unstructured":"Dieffenbach, C. W. et al. General concepts for PCR primer design. PCR Methods Appl. 3 (3), S30-37 (1993).","journal-title":"PCR Methods Appl"},{"key":"ref21","type":"book","article-title":"User Guide for Applied Biosystems","volume-title":"3730\/3730xl DNA Analyzer","year":"2014","unstructured":"Applied Biosystems. User Guide for Applied Biosystems. 3730\/3730xl DNA Analyzer. (2014)."}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/65647\/wild-type-blocking-pcr-combined-with-sanger-sequencing-for-detection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:09:39Z","timestamp":1792598979000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/65647\/wild-type-blocking-pcr-combined-with-sanger-sequencing-for-detection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":21,"journal-issue":{"issue":"210","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3791\/65647","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}